Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000065

Chief Commercial Officer sold 2,770 shares at $33.54 ($92,906)

  • Chief Commercial Officer acquired 6,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Milanova Tsveta · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-24 Exercise or conversion : show line 1 in the form 10b5-1 +6,000 28,892 D
2025-06-24 Sale : show line 2 in the form 10b5-1 −2,770 $33.54 $92,906 26,122 D
Open-market sales · 2,770 sh · avg $33.54 · $92,906

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-24 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −6,000 6,000 D
Loading xslF345X05/wk-form4_1750972990.xml…